#aatd search results

📢 Tomorrow at European Parliament 🇪🇺 “AATD awareness: progress & challenges” 22 Apr 10:00–12:00 CET. Hosted by MEP Chastel & A1EA. In context of European Alpha-1 Awareness Day (25 Apr). Watch live: lnkd.in/eRtn5mZD Join us! #Alpha1 #AATD

🧩 Could unexplained skin marks be a missing piece of your health puzzle? They may signal #AATD Alpha-1 Antitrypsin Deficiency can appear as #Panniculitis — a rare skin condition causing painful red bumps, plaques or nodules due to protein breakdown. 🩺 Noticing these changes?

𝐖𝐨𝐫𝐥𝐝 𝐋𝐢𝐯𝐞𝐫 𝐃𝐚𝐲: AATD & Liver Health Alpha-1 Antitrypsin Deficiency (#AATD) can affect the liver at any age—often silently. Watch for signs like jaundice in infants or unexplained liver disease in adults. Early testing saves lives. Talk to your doctor. 💙

Exploring #AATD & liver health with Dr. Williams JH Griffiths 🏥 Hepatologist specialised in inherited liver disease & transplantation, sharing vital insights for better care. #RareDiseases #LiverHealth #Alpha1Europe #UnitedforAlpha1

Genes control how every cell in the body works. Some genes decide basic traits, such as eye/hair color. Other genes can increase the risk of getting certain diseases, #AATD alpha-1-antitrypsin #AAT #A1AT protein. #svpol Swede don´t get medicin mayoclinic.org/diseases-condi… @MayoClinic

Insightful session on #AATD & Bronchiectasis with Dr. Luciano Corda, founding member of Alpha1 Italy 🇮🇹 & expert pulmonologist 🫁 Sharing knowledge to improve patient care across Europe. #Bronchiectasis #LungHealth #RareDiseases #Alpha1Europe

🟢 Live from Warsaw 🇵🇱 ! The Alpha-1 Europe Alliance AGA is officially underway! 🌍✨ Excited to welcome all our member organisations for a day of collaboration, learning, and shaping the future of #AATD care across Europe. #Alpha1 #Alpha1Europe #PatientVoice #RareDiseases

Really curious about what caused the shortfall in performance of the $krro 1st gen LNP-based #AATD candidate. Could it be in any way related to the underperformance of the $beam and $wve candidates in terms of M-AAT output relative to % transcript correction...and which I

Can persistent jaundice in a newborn be the missing piece? 🧩 It could point to Alpha-1 Antitrypsin Deficiency (#AATD) — a genetic condition where abnormal protein builds up in the liver, causing damage. Early signs matter. Diagnosis is simple: a blood test. Learn more:

Vikings mutation #AATD genetic inheritance alpha-1-antitrypsin deficiency: liver/lungs. #EU-Europe provides drugs, not #svpol! NT-rådet/@TLV_nyheter=1500 Swedes die prematurely=Denmark provides drugs facebook.com/groups/1254338… [email protected] alpha1awarenessday.org #alpha1

Vikings-mutation #AATD genetisk arv: alfa-1-antitrypsinbrist: lever/lungs. #EU-Europa ger läkemedel, inte #svpol! NT-rådet/@TLV_nyheter=1500 svenskar dör i förtid=Denmark ger läkemedlen @alpha1europe facebook.com/groups/1254338… [email protected] alpha1awarenessday.org #alpha1

Important step. A structured algorithm using non-invasive tests and elastography can help identify AATD liver disease earlier. In practice, unexplained mild transaminitis with low platelets should prompt consideration and staged monitoring. #AATD #medx

✈️ Top Gun: Maverick and AATD – An Unexpected Connection Alyssa Gloor shares how Top Gun: Maverick surprisingly echoed her journey as a rare disease patient with #AATD. Read Alyssa's column: bit.ly/4t9OIur #RareDisease #PatientPerspective #TopGun #MedTwitter

Is there a 𝒎𝒊𝒔𝒔𝒊𝒏𝒈 𝒑𝒊𝒆𝒄𝒆 in your health puzzle affecting your breathing? 🧩 It could be Alpha-1 Antitrypsin Deficiency (#AATD)—a genetic condition that can cause lung damage, breathlessness & frequent infections. A simple blood test can help diagnose it. 🔗Learn

Is there a 𝒎𝒊𝒔𝒔𝒊𝒏𝒈 𝒑𝒊𝒆𝒄𝒆 in our awareness of a crucial genetic condition?​🧬 Alpha-1 Antitrypsin Deficiency (#AATD) is caused by mutations in the gene responsible for producing Alpha-1 Antitrypsin, a protein that helps protect the lungs and other tissues. When the

This #WorldHealthDay, we highlight the importance of evidence-based decisions for the #AATD community 🔬 Trust science-based info to: • protect lung, liver & skin health • support early diagnosis • guide treatment decisions • improve quality of life Science drives earlier

Anyone with cirrhosis needs to get find out if they have AATD. This could mean better outcomes in patients with this condition. #AATD

March is national nutrition month and AATD patients can benefit from healthy diet. Generally the lower-inflammatory foods are best. #AATD #nationalnutritionmonth

The @US_FDA has approved the Investigational New Drug (#IND) application for YOLT-202, an in vivo gene-editing therapy for alpha-1 antitrypsin deficiency (#AATD), according to a recent press release. Read more: bit.ly/4draiFV #RareDisease #YOLT202 # #Alpha1

AATD is a genetic condition that can affect even children of those with an abnormal alleles (such as PiZZ) in their genotype. It's largely under diagnosed. #AATD

Marking #RareDiseaseDay by doing #aatd clinic @uhbtrust in a balloon & poster decorated department, with cake for those who wanted it 🎂🙂

Attending Jones Virtual Genetic Medicine Day on Monday, November 25? Join us from 1:00–2:00 PM ET as our CEO & President, @ramaiyar, participates in a panel discussion focused on the role of RNA editing in Alpha-1 Antitrypsin Deficiency (#AATD). #RNAEditing #GeneticMedicine

Learning & networking at European #aatd masterclass. Hosted by pulmonology @MiravitllesMarc @CSLBehring but talking about liver too!

Great to learn from others in Canada & Scandinavia about approaches to accessing #aatd treatment. Lessons: understand the system & partner up to improve power and make change happen 💪🏻

Liver stiffness by elastography as a predictor of subsequent endpoints in PiZZ #aatd #EASLCongress

Breaking news! The U.S. FDA has granted orphan drug designation to KRRO-110 an investigational medicine for the treatment of Alpha-1 Antitrypsin Deficiency (#AATD). The designation underscores the FDA's recognition of the growing need for new treatments for patients living with

Next week, our leadership team will be participating in a panel discussion at the @BMO Genetic Medicines Summit followed by @Piper_Sandler’s Virtual Two-Part Series featuring an AATD-focused fireside chat and expert webinar. $KRRO #AATD

Claims to be the most innovative square mile on the planet. Here to talk #aatd treatment using some exciting new technology @BeamTx press release in 🧵

Join us at 4:30 today at #ASGCT23 to learn about WVE-006, which is on track to be the first #RNAediting investigational therapeutic to enter clinical development. WVE-006 is uniquely designed to correct the mutation that causes #AATD and address both liver and lung disease. $WVE

Great to hear @CPathInstitute are working on generating endpoints for clinical trials in #aatd that are both meaningful to patients & accepted by regulators. Need both to get good treatment out there

ขิงเก่งขิงไวต้องยกให้เค้าเลย🤭🤭 #เนเน่ #Nene郑乃馨 #AATD

Liver fibrosis occurs in ~25% #aatd patients & progresses slowly, possibly slower in the presence of #copd @GingerClarkMD @AATLDConference onlinelibrary.wiley.com/doi/full/10.11…

Over the weekend we met w/ the #AATD patient community at #A1FNC24 & liver specialists at the #EASLCongress to present on WVE-006, our best-in-class #RNAediting candidate for AATD. We remain on track for proof-of-mechanism in patients this year. Thanks for the great discussions!

Korro Bio is pleased to provide a pipeline update, and to announce the initiation of dosing in our REWRITE study investigating KRRO-110 as a potential treatment for Alpha-1 Antitrypsin Deficiency (#AATD). An interim readout is expected in the second half of 2025. Read the full

This morning we announced the submission of the first CTA for WVE-006. WVE-006 is the first-ever RNA editing program to enter clinical development and is designed to address #AATD-related lung disease, liver disease, or both. Read more: bit.ly/484uFU0. $WVE

We spoke with Mariano Pastor (@Alfa1Espana) about the importance of #respiratoryphysiotherapy in patients with #AATD. "Ideally, it should be done regularly." 📊 He also emphasizes: "Data is essential" to improve access to rehabilitation. 🔗 Read it here: tinyurl.com/2uecw58n

Exciting day talking #aatd trials with UK colleagues and @Kamada_Pharma More info 👉🏻 innovaate-study.com/en/home/

A pleasure to talk about #aatd in the rare disease symposium #BASL2024 Quick tour through diagnosis, liver disease progression & clinical trials. Lovely day for it too, topped off by a delicious slice of hazelnut cake before the journey home 😋

CRISPR Therapeutics Unveils Promising Preclinical Data for CTX460™, a SyNTase™ Gene Editing Therapy Targeting Alpha-1 Antitrypsin Deficiency - For More Information Visit shorturl.at/SEcfo @CRISPRTX #AATD #Rare_Diseases #OrphanDrugs #Alpha1_Antitrypsin_Deficiency

Great talk on exercise conceptualising how to treat limitations @Marian_Ramon. However #aatd evidence lacking v #copd and effects on muscle may be ⬇️. More research needed!